Stockholm (ots/PRNewswire) - - Report Benchmarks the Current State of Lung Cancer Care Across Europe The fragmented organization and management of lung cancer diagnosis and care in many European countries are exacerbating already poor survival rates amongst patients with the disease. That is the conclusion of a new report from a group of leading ...
Chicago, Illinois (ots/PRNewswire) - - Tarceva Extends Length and Quality of Life in Largest Non-Small Cell Lung Cancer (NSCLC) Phase IV Study Ever Conducted - For non-US and non-UK Media Only New data presented at ASCO 2008 from TRUST(1), the largest non-small cell lung cancer (NSCLC) Phase IV trial ever conducted, show that a broad range of NSCLC ...
Collegeville, Pennsylvania (ots/PRNewswire) - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the Company's investigational 13-valent pneumococcal conjugate vaccine for infants and toddlers. Wyeth is ...
Toronto (ots/PRNewswire) - - Data Presented at the 2008 International Conference of the American Thoracic Society Laboratorios Almirall, S.A. and Forest Laboratories, Inc. today presented results from four clinical trials assessing the efficacy and safety of aclidinium bromide, an investigational ...
Shanghai, China (ots/PRNewswire) - China International Automotive Electronics Show -- Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of the new fully integrated fractional-N PLL RF transmitter IC ATA5749 for car access and TPMS applications. The new device is one of the very few ...
Basel, Switzerland (ots/PRNewswire) - Patients with breast or colorectal cancer, two of the world's most common cancers, can expect further treatment advances with Avastin(R) (bevacizumab) and Herceptin(R) (trastuzumab) following new data that is being presented at the 44th American Society of Clinical Oncology (ASCO) annual meeting in Chicago at the end of May. ...
. Total Group revenues up 29.1 percent to EUR 339.7 million . After-tax profit up 244.4 percent to EUR 12.4 million . Earnings per share up from EUR 0.20 to EUR 0.70 . Full-year forecast for 2008 reaffirmed ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies/Quarterly ...
St. Peter Port, Guernsey (ots/PRNewswire) - European Capital Limited ("European Capital") (LSE: ECAS) announced today its second quarter 2008 dividend and its results for the first quarter of 2008. SECOND QUARTER 2008 DIVIDEND DECLARATION European Capital's Board of Directors has declared a ...
Barcelona, Spain (ots/PRNewswire) - - Patients Treated with XIENCE V in SPIRIT III Trial Experience Better Long-Term Clinical Outcomes, Lower Rates of Stent Thrombosis than Patients Treated with TAXUS Long-term data presented for the first time today from the SPIRIT III trial, Abbott's U.S. pivotal trial ...
Washington, Dc (ots/PRNewswire) - - International Reach of 'Young Minds in Psychiatry' Awards is Boosted With AstraZeneca Support For the first time, a researcher from China has received one of the American Psychiatric Association's (APA) prestigious "Young Minds in Psychiatry" awards, which were ...
Paris (ots/PRNewswire) - - New Analysis of ASCOT-BPLA Data Identifies Major Predictors of NOD Among Hypertensives A new analysis of data from the landmark Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA) published today in Diabetes Care has identified the major predictors of new-onset diabetes (NOD) in patients with ...
Basel, Switzerland (ots/PRNewswire) - - No Nucleoside/Nucleotide Analogue Treatments Have Shown Similar Results New data revealed today show that a significant number of patients with chronic hepatitis B virus infection who received PEGASYS(R) (peginterferon alfa-2a) treatment achieved clearance of ...
Ingelheim, Germany (ots/PRNewswire) - - For non-US Healthcare Media - Abstract # 163O. von Pawel. Proffered Papers 6 - Advanced NSCLC - Latest Phase II Data for Boehringer Ingelheim's New Cancer Drug in Development Presented Monotherapy treatment with the triple angiokinase inhibitor(1) BIBF 1120 ...
. Total Group revenues up 23.3 percent to EUR 1.2 billion . After-tax profit exceeds expectations, up 111.4 percent to EUR 74.4 million . Doubling of dividend to EUR 1.00 per share planned . Full order books deliver bright prospects for 2008 ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. companies/financial statements Schrobenhausen (euro adhoc) - April 22, 2008 - The global construction and ...
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media, Outside the US Only Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus(R) 80/25 in all 27 EU member ...
Deutsche Effecten- und Wechsel-Beteiligungsges. AG
- Unique radio communication and tracking system with a broad range of applications in the strong growth RTLS market - 11 million Euro financing round for further expansion ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. merger, acquisition and takeover Jena/London/Berlin, 14 April 2008 (euro adhoc) - Deutsche Effecten- und ...
Toronto, Canada (ots/PRNewswire) - - Press Conference and Live Web Cast KPMG LLP will release its 7th Competitive Alternatives Study, ranking the competitive business cost advantage of 10 countries and 136 cities, on March 27 at 09:30 EST, 06:30 PST, 13:30 GMT, via a news conference, conference call, and Web cast. The announcement will be made in Toronto, ...
Toronto (ots/PRNewswire) - - Press Conference and Live Web Cast TORONTO, March 19 /PRNewswire/ -- KPMG LLP will release its 7th Competitive Alternatives Study, ranking the competitive business cost advantage of 10 countries and 136 cities, on March 27 at 09:30 EST, 06:30 PST, 13:30 GMT, via a news conference, conference call, and Web cast. The announcement ...
Horsholm, Denmark (ots/PRNewswire) - - Results Show Highly Significant Effect on Rhinoconjunctivitis (Hay Fever) and Asthma Symptoms in Children from age 5 to 16 Years-old ALK-Abelló yesterday presented successful Phase III clinical study results with GRAZAX(R) in children at the American Academy ...
Paris (ots/PRNewswire) - - Preliminary Findings from the Largest-Ever Study of Treatments for Diabetes Provide no Evidence That Intensive Treatment to Lower Blood Glucose (Sugar) Increases Risk of Death Interim results from the ADVANCE Study, involving 11,140 high-risk patients with type 2 diabetes, provide no evidence of an increased risk of death among ...
St. Peter Port, Guernsey (ots/PRNewswire) - - Forecasts 68% Dividend Increase in 2008 to euro 0.62 - Forecasts Q1 Dividend of euro 0.15 European Capital Limited ("European Capital") (LSE: ECAS) announced today its results for the fourth quarter and full year of 2007. 2007 RESULTS European Capital announced today its results for the quarter ...
Rousset, France and Velizy, France (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML), announced today that the recent Payment Card Industry (PCI) and EMV approvals of Thales' Artema S10 PIN Pad is the result of a long-term collaboration between the two companies. Thales' Artema S10 PIN pad, which combines high performance with high security, is powered by ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 06.02.2008 » Data from 50 patients reveal statistically significant viral load reduction and favorable safety profile » Data confirm findings from Interim Analysis from Q3 2007 » Further ...
Basel, Switzerland (ots/PRNewswire) - - Many More Patients Can Now Benefit From Oral Chemotherapy That Significantly Reduces Treatment Time Roche announced today that the European Commission has approved its oral chemotherapy Xeloda (capecitabine) for the treatment of metastatic colorectal cancer in combination with any chemotherapy in all lines of ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 01.02.2008 D i e t l i k o n, 1 February 2008 - In response to Implenia's request, the SWX Swiss Exchange's Disclosure Office has recommended that Implenia AG and Russian Land Limited in ...
San Diego (ots/PRNewswire) - - Revenues US$2.44 Billion, Diluted EPS US$0.46 - Pro Forma Diluted EPS US$0.52, up 21 percent year-over-year - Reaffirms Fiscal 2008 Pro Forma Earnings Guidance Qualcomm Incorporated (Nasdaq: QCOM) today announced results for the first fiscal quarter of 2008 ended December 30, 2007. Total Qualcomm (GAAP) First Quarter Results Total Qualcomm results are reported in ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Stock Activity 15.01.2008 Hörsching, January 15, 2008 (VSE: PYT) - POLYTEC GROUP today announced a holding of 1,006,009 or 9.59% of GRAMMER AGs ordinary shares. GRAMMER AG is listed in the ...
Basel, Switzerland (ots/PRNewswire) - Following an announcement from Schering-Plough, Roche today affirmed the value of PEGASYS(R) (peginterferon alfa-2a) in combination with COPEGUS(R) (Roche's brand of ribavirin) as the market-leading treatment for patients with hepatitis C. Despite clear biases in the design of the "IDEAL" study that potentially favoured patients taking PegIntron(TM) (peginterferon alfa-2b) regimens ...
San Diego (ots/PRNewswire) - - Increases First Quarter Fiscal 2008 Revenue and Earnings per Share Guidance Qualcomm Incorporated (Nasdaq: QCOM) today updated its financial guidance for the first fiscal quarter ending December 30, 2007. The following statements are forward looking and actual results may differ materially. Please see "Note Regarding ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information 14.12.2007 D i e t l i k o n, 14 December 2007. An extraordinary general meeting of Swiss construction services company Implenia AG decided by an overwhelming majority to ...